As for AVERROES, he considers the study of value mainly as proof of safety.
“I would have been shocked if it didn’t show efficacy. We already know that an antithrombin is going to be more effective than aspirin; there’s nothing new there,” the cardiologist said.
AVERROES was sponsored by Bristol-Myers Squibb and Pfizer. Dr. Connolly disclosed receiving research grants and lecture and consulting fees from the two companies. Dr. Arnesen and Dr. Brindis reported no financial conflicts.